<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02536053</url>
  </required_header>
  <id_info>
    <org_study_id>324/13/03/02/2014/2</org_study_id>
    <nct_id>NCT02536053</nct_id>
  </id_info>
  <brief_title>Outcomes in Lower Extremity Soft Tissue Sarcoma Patients After Limb Salvage</brief_title>
  <official_title>Functional Outcomes and Health Related Quality of Life in Lower Extremity Soft Tissue Sarcoma Patients After Limb Salvage: A Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to:

        1. validate the Finnish version of the Musculoskeletal Tumor Society scale and the Toronto
           Extremity Salvage Score lower extremity sections and to

        2. assess the functional ability and health-related quality of life (HRQoL) of lower
           extremity sarcoma patients who have undergone limb salvage surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The first purpose of this study is to validate the Finnish version of the Musculoskeletal
      Tumor Society scale and the Toronto Extremity Salvage Score upper extremity sections. The
      second purpose is to chart the functional capabilities and health-related quality of life
      (HRQoL) of upper extremity sarcoma patients who have undergone limb salvage surgery with
      local or free flaps.

      Patient hospital records are retrospectively reviewed to chart the demographic and clinical
      data.

      The recruitment of patient takes place at the outpatient clinic of Department of Oncology,
      Helsinki University Hospital. The study includes a cross-sectional assessment at one year
      follow-up with five validated questionnaires. A follow-up is conducted three years after
      surgery in the outpatient clinic.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validity of the lower-limb Musculoskeletal Tumor Society score and the Toronto Extremity Salvage Score</measure>
    <time_frame>two to five years</time_frame>
    <description>The validity is studied</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reliability of the lower-limb Musculoskeletal Tumor Society score and the Toronto Extremity Salvage Score</measure>
    <time_frame>two to five years</time_frame>
    <description>The test-retest reliability is studied</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health-related quality of life after limb salvage</measure>
    <time_frame>two to five years</time_frame>
    <description>Assessment of health-related quality of life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the functional ability after limb salvage</measure>
    <time_frame>two to five years</time_frame>
    <description>Assessment of functional ability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Questionnaire-Core 30</measure>
    <time_frame>two to five years</time_frame>
    <description>Health-related quality of life assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The 15-dimensions health-related quality of life instrument</measure>
    <time_frame>two to five years</time_frame>
    <description>Health-related quality of life assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Musculoskeletal Tumor Society score lower extremity section</measure>
    <time_frame>two to five years</time_frame>
    <description>Functional assessment of the reconstructed limb</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Toronto Extremity Salvage Score lower extremity section</measure>
    <time_frame>two to five years</time_frame>
    <description>Functional assessment of the reconstructed limb</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Limb Salvage</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Limb salvage</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Lower extremity sarcoma patient who underwent limb-salvage surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lower extremity soft tissue sarcoma locating in between hip/gluteus to foot

          -  No metastasis at the time of diagnosis

          -  Undergone limb salvage surgery

          -  A minimum of 1 year follow-up

          -  Written consent

          -  Age &gt; 18

        Exclusion Criteria:

          -  Age &lt;18

          -  No limb-salvage surgery due to sarcoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erkki J Tukiainen, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University Hospital and University of Helsinki</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carl Blomqvist, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University Hospital and University of Helsinki</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gilber Kask, MD</last_name>
    <email>gilber.kask@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ian Barner-Rasmussen, MD, PhD</last_name>
    <email>ian.barner-rasmussen@hus.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cancer center, Helsinki University Hospital and University of Helsinki</name>
      <address>
        <city>Helsinki</city>
        <state>Helsinki and Uusimaa</state>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jussi Repo, MD</last_name>
      <phone>+358443593100</phone>
      <email>mrjussirepo@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ian Barner-Rasmussen, MD, PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Gilber Kask, M, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2015</study_first_submitted>
  <study_first_submitted_qc>August 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2015</study_first_posted>
  <last_update_submitted>August 17, 2016</last_update_submitted>
  <last_update_submitted_qc>August 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Jussi Repo</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>[E04.100.814.603]</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

